127 related articles for article (PubMed ID: 36378234)
1. GENETIC VARIANTS AND SERUM PROFILES OF CYTOKINES IN COVID-19 SEVERITY.
Alefishat E; Mousa M; Albreiki M; Jelinek HF; Al Halwachi Z; Khalili M; Waasia F; Uddin M; Al Kaabi N; Mahboub B; Albataineh MT; Tay GK; Alsafar HS;
Shock; 2023 Jan; 59(1):58-65. PubMed ID: 36378234
[TBL] [Abstract][Full Text] [Related]
2. Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'.
Smieszek SP; Przychodzen BP; Polymeropoulos VM; Polymeropoulos CM; Polymeropoulos MH
Cytokine; 2021 Dec; 148():155662. PubMed ID: 34353696
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Severity Shifts the Cytokine Milieu Toward a Proinflammatory State in Egyptian Patients: A Cross-Sectional Study.
Salem ML; Eltoukhy MM; Shalaby RE; Okasha KM; El-Shanshoury MR; Attia MA; Hantera MS; Hilal A; Eid MA
J Interferon Cytokine Res; 2023 Jun; 43(6):257-268. PubMed ID: 37252793
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
Balakrishnan VS; Guo D; Rao M; Jaber BL; Tighiouart H; Freeman RL; Huang C; King AJ; Pereira BJ;
Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
[TBL] [Abstract][Full Text] [Related]
6. Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation.
Jelinek HF; Mousa M; Alkaabi N; Alefishat E; Daw Elbait G; Kannout H; AlHumaidan H; Selvaraj FA; Imambaccus H; Weber S; Uddin M; Abdulkarim F; Mahboub B; Tay G; Alsafar H
Front Med (Lausanne); 2021; 8():759648. PubMed ID: 35096865
[No Abstract] [Full Text] [Related]
7. Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population.
Falahi S; Zamanian MH; Feizollahi P; Rezaiemanesh A; Salari F; Mahmoudi Z; Gorgin Karaji A
Cytokine; 2022 Jun; 154():155889. PubMed ID: 35461173
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
9. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
10. Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases.
Ghulam U; Nazim F; Farooqui N; Rizwan-Ul-Hasan S; Anwar MF; Ahmed K; Jamal A; Kayani HA; Mughal N; Hussain A; Sarria-Santamera A; Abidi SH
PLoS One; 2022; 17(12):e0279270. PubMed ID: 36584119
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID-19 risk and severity in an Iranian population.
Rokni M; Sarhadi M; Heidari Nia M; Mohamed Khosroshahi L; Asghari S; Sargazi S; Mirinejad S; Saravani R
Cell Biol Int; 2022 Jul; 46(7):1109-1127. PubMed ID: 35521908
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study.
Darmadi D; Pakpahan C; Ruslie RH; Rezano A
F1000Res; 2021; 10():1246. PubMed ID: 35136584
[No Abstract] [Full Text] [Related]
13. Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity.
Deng X; Tang K; Wang Z; He S; Luo Z
J Epidemiol Glob Health; 2024 Jun; 14(2):363-378. PubMed ID: 38376765
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort.
Ruytinx P; Vandormael P; Fraussen J; Pieters Z; Thonissen S; Hellings N; Stinissen P; Callebaut I; Penders J; Vanhove K; Kieffer D; Rummens JL; Valkenborgh T; Messiaen P; Stessel B; Mesotten D; Somers V
Sci Rep; 2023 Nov; 13(1):19322. PubMed ID: 37935729
[TBL] [Abstract][Full Text] [Related]
15. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of IL6 gene -174G > C and -597G > A are associated with the risk of COVID-19 severity.
Verma S; Verma S; Khan FH; Siddiqi Z; Raza ST; Abbas M; Mahdi F
Int J Immunogenet; 2023 Feb; 50(1):5-11. PubMed ID: 36323530
[TBL] [Abstract][Full Text] [Related]
17. Distinct cytokine profiles associated with COVID-19 severity and mortality.
Dorgham K; Quentric P; Gökkaya M; Marot S; Parizot C; Sauce D; Guihot A; Luyt CE; Schmidt M; Mayaux J; Beurton A; Le Guennec L; Demeret S; Ben Salah E; Mathian A; Yssel H; Combadiere B; Combadiere C; Traidl-Hoffmann C; Burrel S; Marcelin AG; Amoura Z; Voiriot G; Neumann AU; Gorochov G
J Allergy Clin Immunol; 2021 Jun; 147(6):2098-2107. PubMed ID: 33894209
[TBL] [Abstract][Full Text] [Related]
18. Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease.
Vakil MK; Mansoori Y; Al-Awsi GRL; Hosseinipour A; Ahsant S; Ahmadi S; Ekrahi M; Montaseri Z; Pezeshki B; Mohaghegh P; Sohrabpour M; Bahmanyar M; Daraei A; Dadkhah Jouybari T; Tavassoli A; Ghasemian A
J Med Virol; 2022 Sep; 94(9):4088-4096. PubMed ID: 35538614
[TBL] [Abstract][Full Text] [Related]
19. IL-17A )rs2275913; G197A) gene polymorphism as predictor for disease severity and its correlation with IL-17 serum levels in COVID-19 patients.
Rushdy M; Elsayed MS; Ahmed R; Gaber AG; El-Asady R
Egypt J Immunol; 2022 Jul; 29(3):90-98. PubMed ID: 35758972
[TBL] [Abstract][Full Text] [Related]
20. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
